Search Results - "RIDA, W"

Refine Results
  1. 1

    Effect of Sodium Carboxymethylcellulose and Sorbitol on Anti-Peptic Ulcer Activity of Anredera cordifolia Leaves Extract by Ulfah, Maria, Rachmaniar, Revika, Sudrajat, Egi MR, Fadla, Rida W., Pinuji, Hary S.

    “…Anredera cordifolia or binahong is one of the Indonesian medicinal plants that is used to treat peptic ulcer. The purpose of this study was to evaluate the…”
    Get full text
    Journal Article
  2. 2

    Lot Consistency as an Equivalence Problem by Lachenbruch, P. A., Rida, W., Kou, J.

    Published in Journal of biopharmaceutical statistics (24-12-2004)
    “…One requirement for licensure of a vaccine in the United States is demonstration by the manufacturer of consistently produced lots of vaccine. Demonstration of…”
    Get full text
    Journal Article
  3. 3

    Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations by Longini Jr, Ira M., Sagatelian, Karen, Rida, Wasima N., Halloran, M. Elizabeth

    Published in Statistics in medicine (30-05-1998)
    “…Vaccination can have important indirect effects on the spread of an infectious agent by reducing the level of infectiousness of vaccinees who become infected…”
    Get full text
    Journal Article
  4. 4

    Mortality in children and adolescents with sickle cell disease by LEIKIN, S. L, GALLAGHER, D, KINNEY, T. R, SLOANE, D, KLUG, P, RIDA, W

    Published in Pediatrics (Evanston) (01-09-1989)
    “…A study of the natural history of sickle hemoglobinopathies was begun in March 1979. By August 1987, a total of 2824 patients <20 years of age were enrolled…”
    Get full text
    Journal Article
  5. 5

    ASSESSING THE EFFECT OF HIV VACCINATION ON INFECTIOUSNESS by RIDA, WASIMA N.

    Published in Statistics in medicine (30-11-1996)
    “…Traditionally, measures of vaccine efficacy have focused on a vaccine's ability to prevent infection or disease. HIV vaccination, however, may have important…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Asymptotic Properties of Some Estimators for the Infection Rate in the General Stochastic Epidemic Model by Rida, Wasima N.

    “…Some estimators for the infection rate in the general stochastic epidemic model are presented. The first estimator follows the approach of maximum likelihood…”
    Get full text
    Journal Article
  7. 7

    HIV vaccine trials: some design issues including sample size calculation by Dixon, D O, Rida, W N, Fast, P E, Hoth, D F

    “…Anticipating the availability of one or more candidate HIV vaccines for efficacy testing in the next few years, public health agencies are now planning for the…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Continuous noninvasive monitoring of cardiac output with esophageal doppler ultrasound during cardiac surgery by MARK, J. B, STEINBROOK, R. A, GUGINO, L. D, MADDI, R, HARTWELL, B, SHEMIN, R, DISESA, V, RIDA, W. N

    Published in Anesthesia and analgesia (01-10-1986)
    “…Esophageal Doppler ultrasonography offers a continuous and noninvasive alternative to standard thermodilution cardiac output monitoring. A total of 372…”
    Get full text
    Journal Article
  10. 10

    Statistical issues in the design of HIV vaccine trials by Schaper, C, Fleming, T R, Self, S G, Rida, W N

    Published in Annual review of public health (01-01-1995)
    “…HIV vaccine trials present significant challenges related to trial endpoints, vaccine efficacy measurement, and the role of nonvaccine interventions. Infection…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    AIDS vaccines and preexposure prophylaxis: is synergy possible? by Excler, Jean-Louis, Rida, Wasima, Priddy, Frances, Gilmour, Jill, McDermott, Adrian B, Kamali, Anatoli, Anzala, Omu, Mutua, Gaudensia, Sanders, Eduard J, Koff, Wayne, Berkley, Seth, Fast, Patricia

    Published in AIDS research and human retroviruses (01-06-2011)
    “…While the long-term goal is to develop highly effective AIDS vaccines, first generation vaccines may be only partially effective. Other HIV prevention…”
    Get more information
    Journal Article
  14. 14

    Some statistical issues in HIV vaccine trials by Rida, W N, Lawrence, D N

    Published in Statistics in medicine (15-10-1994)
    “…Efficacy trials of prophylactic HIV vaccines will be among the most difficult clinical trials ever attempted. Not only will there be challenges with the…”
    Get more information
    Journal Article
  15. 15

    A strategy for accelerating the development of preventive AIDS vaccines by EXCLER, Jean-Louis, RIDA, Wasima, PRIDDY, Frances, FAST, Patricia, KOFF, Wayne

    Published in AIDS (London) (12-11-2007)
    “…An effective vaccine against HIV-1 is urgently needed. Many candidate vaccines are currently in or are approaching clinical trials. The selection of vaccines…”
    Get full text
    Journal Article
  16. 16

    Automated sphygmomanometer in spinal cord injured patients during head-up tilt: an evaluation by Hammond, M C, Hinde, J D, Rida, W

    “…Fifteen patients with spinal cord injury above T6 who were complete or had sensory sparing only were monitored during head-up tilt to evaluate the clinical…”
    Get more information
    Journal Article
  17. 17

    Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA by Osmanov, S

    Published in AIDS (London) (19-02-2007)
    “…This report summarizes the discussions and recommendations from a consultation held in New York City, USA (31 January-2 February 2006) organized by the joint…”
    Get full text
    Journal Article Conference Proceeding
  18. 18

    Intermediate-size trials for the evaluation of HIV vaccine candidates : A workshop summary by RIDA, W, FAST, P, HOFF, R, FLEMING, T

    “…There has been considerable debate over what evidence from preclinical and clinical studies is required to advance an HIV vaccine candidate to phase III…”
    Get full text
    Journal Article Conference Proceeding
  19. 19
  20. 20

    Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshop by Albert, J M, Ioannidis, J P, Reichelderfer, P, Conway, B, Coombs, R W, Crane, L, Demasi, R, Dixon, D O, Flandre, P, Hughes, M D, Kalish, L A, Larntz, K, Lin, D, Marschner, I C, Muñoz, A, Murray, J, Neaton, J, Pettinelli, C, Rida, W, Taylor, J M, Welles, S L

    Published in Statistics in medicine (15-11-1998)
    “…This paper summarizes the proceedings of an NIAID-sponsored workshop on statistical issues for HIV surrogate endpoints. The workshop brought together…”
    Get full text
    Journal Article